Domestic pharmaceutical companies are investing in GLP-1 analog manufacturing, driven by: Rising diabetes and obesity prevalence Government focus on affordable healthcare Established biosimilar capabilities Recent trends include: Early-stage launches of GLP-1 analog generics by Indian manufacturers Increased partnerships between global and Indian firms Expansion of domestic manufacturing capacity These developments will significantly boost local demand for drug delivery devices, particularly low-cost injection systems
My digestion improved, and the feeling of fullness lasted longer
Tosin, is a triple board-certified internal medicine, obesity medicine, and lifestyle medicine physician and a Fellow of the American College of Physicians, with over twenty years of clinical experience
Gas is typically produced in one of two ways: when you swallow air or when bacteria break down the food that you eat
Obesity wasn't considered a disease until a decade ago, meaning that most physicians are not trained in this area and it remains woefully underrepresented in claims data
Research suggests that some lean body mass can be lost during significant weight loss, which is why strength training is often encouraged